Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

MetLife : Shareholders Approve Proposal at Special Meeting

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/19/2017 | 10:18pm CEST

MetLife, Inc. (NYSE:MET) announced that the company’s shareholders today approved changes to dividend payment tests in the company’s charter. These changes avoid potential restrictions on preferred stock and common stock dividends and repurchases of common stock, which could have occurred as a result of the Aug. 4, 2017 spin-off of Brighthouse Financial, Inc.

The MetLife board of directors recommended a vote in favor of the proposal. The final vote total will be included in a Form 8-K that will be filed with the U.S. Securities and Exchange Commission within four business days following today’s meeting. Further details on the proposals can be found in the special meeting proxy statement, which is available in the Investor Relations section of www.metlife.com.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Cautionary Note Regarding Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” “continuing,” “potential,” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of MetLife, Inc., its subsidiaries and affiliates. These statements are based on current expectations and the current economic environment. They involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.’s most recent Annual Report on Form 10-K (the “Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”), any Quarterly Reports on Form 10-Q filed by MetLife, Inc. with the SEC after the date of the Annual Report under the captions “Note Regarding Forward-Looking Statements” and “Risk Factors,” and other filings MetLife, Inc. makes with the SEC. MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later become aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the SEC.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
10/19 METLIFE : Shareholders Approve Proposal at Special Meeting
10/14 INTERNATIONAL BUSINESS MACHINES : IBM brings insurance platform to market
10/14 METLIFE : Selected as a Provider for the U.S. Department of Veterans Affairs Den..
10/11 IBM : Introduces Industry Platform Designed Specifically for Insurers
10/11 METLIFE : Announces 6 Finalists for "collab 2.0"
10/10 METLIFE : Announces 6 Finalists for “collab 2.0”
10/05 METLIFE : Tenth year in a row that MetLife is recognized by Dave Thomas Foundati..
10/04 METLIFE : Auto & Home® Introduces 100% Digital Products on Guidewire Platform
10/04 A.M. BEST : Affirms Credit Ratings of MetLife Inc. and Its Subsidiaries
10/04 METLIFE : to Hold Conference Call for Third Quarter 2017 Results
More news
News from SeekingAlpha
10/18 BRIGHTHOUSE FINANCIAL : Fundamental Headwinds Priced In; 25% Upside For Insuranc..
10/17 Prudential up more than 1% after Citi upgrade
10/16 Dividend Growth Portfolio Update
10/14 Stocks to watch next week
10/13 Valuing Brighthouse Financial. Is It Deeply Discounted?
Financials ($)
Sales 2017 63 809 M
EBIT 2017 5 878 M
Net income 2017 3 688 M
Debt 2017 -
Yield 2017 3,04%
P/E ratio 2017 16,51
P/E ratio 2018 10,60
Capi. / Sales 2017 0,88x
Capi. / Sales 2018 0,89x
Capitalization 56 225 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 55,5 $
Spread / Average Target 4,7%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-2.02%56 024
AXA5.46%72 382
PRUDENTIAL12.81%62 878
PRUDENTIAL FINANCIAL INC4.64%46 863
MANULIFE FINANCIAL CORP.7.18%40 999
AFLAC INCORPORATED21.34%33 104